Sumulay, Baby Boy I.

HRN: 27-05-64  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2025
AMPICILLIN 500MG (VIAL)
05/01/2025
05/08/2025
IV
175mg
Q12hours
Neonatal Sepsis Sec To NID
Waiting Final Action 
05/01/2025
CEFOTAXIME 500MG (VIAL)
05/01/2025
05/08/2025
IV
175mg
Q8hours
Neonatal Sepsis Sec To NID
Waiting Final Action 
05/01/2025
CEFOTAXIME 500MG (VIAL)
05/01/2025
05/07/2025
IVTT
270mg
Q12h
Neonatal Sepsis
Waiting Final Action 
05/05/2025
OXACILLIN 500MG (VIAL)
05/05/2025
05/11/2025
IVTT
90mg
Q6h
Sepsis
Waiting Final Action 
05/07/2025
MUPIROCIN 2%, 15G (TUBE)
05/07/2025
05/13/2025
IV
2%
TID
Post IV Site
Waiting Final Action 
05/08/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/08/2025
05/15/2025
IV
350g
Q12
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: